Trials / Recruiting
RecruitingNCT06993454
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- AdventHealth Translational Research Institute · Academic / Other
- Sex
- All
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The overall aim of this study is to investigate the effects of exercise on the amount of glucose that is made by the liver in people with and without Type 2 diabetes (T2D) and hepatic steatosis (fatty liver).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Magnetic Resonance Liver Assessment | Liver fat will be measured by MR imaging to assess level of hepatic steatosis. |
| OTHER | Bike Exercise VO2max | Maximal fitness measured by cycle ergometer. |
| OTHER | DEXA | Measure body composition (fat and lean body mass). |
Timeline
- Start date
- 2025-04-25
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2025-05-28
- Last updated
- 2026-04-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06993454. Inclusion in this directory is not an endorsement.